Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review

BACKGROUND: Dual anti-human epidermal growth factor receptor 2 (HER2) therapies have been shown to improve outcomes of HER2-positive breast cancer patients. We undertook a systematic review to compare treatment outcomes for patients who received single or combined anti-HER2 therapies. METHODS: We id...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao, Zhang, Xin-Ji, Zhang, Tian-Yi, Yu, Fei-Fei, Wei, Xin, Li, Ye-Sheng, He, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161893/
https://www.ncbi.nlm.nih.gov/pubmed/25164542
http://dx.doi.org/10.1186/1471-2407-14-625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161893/
https://www.ncbi.nlm.nih.gov/pubmed/25164542
http://dx.doi.org/10.1186/1471-2407-14-625

Ejemplares similares